{"id":"W2749228458","doi":"10.1016/j.conctc.2017.08.007","title":"Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Contemporary Clinical Trials Communications","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai; Hokkaido University; Chugai Pharmaceutical; Eisai Canada; AYUMI Pharmaceutical; Daiichi-Sankyo; Daiichi Sankyo Europe; Takeda Pharmaceutical Company","keywords":"Infliximab; Discontinuation; Medicine; Clinical endpoint; Randomized controlled trial; Adverse effect; Internal medicine; Dosing; Clinical trial; Gastroenterology; Surgery; Tumor necrosis factor alpha","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04109135,0.0002300408,0.003674633,0.0001862361,0.0003485788,0.00009580946,0.0004790836,0.0001813925,0.000005277675],"category_scores_gemma":[0.07146989,0.0001382801,0.0004564452,0.0001251595,0.0008649988,0.0004040291,0.0002514416,0.0004439792,1.063809e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003440291,"about_ca_system_score_gemma":0.0005242139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001089216,"about_ca_topic_score_gemma":0.0001778631,"domain_scores_codex":[0.984178,0.008678371,0.006075468,0.0004184758,0.0004475357,0.0002021624],"domain_scores_gemma":[0.9715939,0.0223766,0.003586953,0.001578749,0.0007327963,0.0001309689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7334653,0.007872407,0.2494342,0.00003124071,0.0002755725,3.84667e-7,0.0006716621,6.531737e-7,0.00003529199,0.00004217518,0.0001162838,0.008054906],"study_design_scores_gemma":[0.9226138,0.004831842,0.0679387,0.001557213,0.00003610718,2.499953e-7,0.001127495,0.0008632638,0.00001746303,0.0004376088,0.0004502619,0.0001260142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6539562,0.0004206074,0.0001542666,0.001239342,0.00005551908,0.3440978,0.00001705882,0.000009822494,0.00004941267],"genre_scores_gemma":[0.7970777,0.0004845418,0.0004553551,0.00001374409,0.00004352389,0.2018164,0.0000670154,0.00002093932,0.00002080368],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1891485,"threshold_uncertainty_score":0.9873983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2497248741944423,"score_gpt":0.5058197798685078,"score_spread":0.2560949056740656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}